We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Oxford BioDynamics plc (OBD) Ordinary 1p Shares

Sell:40.00p Buy:42.80p 0 Change: 0.90p (2.20%)
Market closed Prices as at close on 3 December 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:40.00p
Buy:42.80p
Change: 0.90p (2.20%)
Market closed Prices as at close on 3 December 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:40.00p
Buy:42.80p
Change: 0.90p (2.20%)
Market closed Prices as at close on 3 December 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Oxford BioDynamics plc is a United Kingdom-based biotechnology company. The Company is engaged in advancing personalized healthcare by developing and commercializing medicine tests for life-changing diseases. It has developed a three dimensional (3D) genomic biomarker platform, EpiSwitch, which builds molecular diagnostic classifiers for prediction of response to therapy, patient prognosis, disease diagnosis and subtyping, and residual disease monitoring in a range of indications. The platform discovers, evaluates, validates and monitors of biomarkers known as chromosome conformation signatures (CCSs). CCSs provides a compelling, stable framework from which changes in the regulation of a genome can be analyzed, long before the results of these epigenetic changes manifest themselves as obvious abnormalities. EpiSwitch supports precision medicine initiatives, including prediction of response to therapy, patient prognosis, disease diagnosis and subtyping, and residual disease monitoring.

Contact details

Address:
26 Beaumont Street
OXFORD
OX1 2NP
United Kingdom
Telephone:
+44 (01865) 518910
Website:
www.oxfordbiodynamics.com/

Important dates

Future events
There are no future events available.
Past events
General meeting 11 November 2021 11/11/21
Interim results 15 June 2021 15/06/21
AGM 24 March 2021 24/03/21
Annual report 23 February 2021 23/02/21
Final results 28 January 2021 28/01/21

General stock information

EPIC:
OBD
ISIN:
GB00BD5H8572
Market cap:
£40.14 million
Shares in issue:
100.35 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Jon Anthony Joseph Burrows
    Chief Executive Officer, Executive Director
  • Paul Stockdale
    Chief Financial Officer, Executive Director
  • Alexandre Akoulitchev
    Chief Scientific Officer, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.